Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

被引:0
作者
Ellie Kelepouris
Wendy St. Peter
Joshua J. Neumiller
Eugene E. Wright
机构
[1] University of Pennsylvania,Division of Renal Electrolyte and Hypertension
[2] University of Minnesota,undefined
[3] Hennepin Healthcare Research Institute,undefined
[4] Washington State University,undefined
[5] Charlotte Area Health Education Center,undefined
来源
Diabetes Therapy | 2023年 / 14卷
关键词
Chronic kidney disease; Type 2 diabetes mellitus; Multidisciplinary care; Multidisciplinary team; Care optimization; Prevention;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes is the leading cause of chronic kidney disease (CKD), a condition associated with significant morbidity and mortality. As these patients have a high risk of developing cardiovascular disease and end-stage kidney disease, there is a need for early detection and early initiation of appropriate therapeutic interventions that slow disease progression and prevent adverse outcomes. Due to the complex nature of diabetes and CKD management, a holistic, patient-centered, collaborative care approach delivered by a coordinated multidisciplinary team (ideally including a clinical pharmacist as part of a comprehensive medication management program) is needed. In this review, we discuss the barriers to effective care, the current multidisciplinary approach used for CKD prevention and treatment, and the potential ways that the multidisciplinary management of CKD associated with type 2 diabetes mellitus can be refined to improve patient outcomes.
引用
收藏
页码:1111 / 1136
页数:25
相关论文
共 298 条
[1]  
Cockwell P(2020)The global burden of chronic kidney disease Lancet 395 662-664
[2]  
Fisher LA(2018)Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 392 1736-1788
[3]  
Afkarian M(2013)Kidney disease and increased mortality risk in type 2 diabetes J Am Soc Nephrol 24 302-308
[4]  
Sachs MC(2021)Overcoming barriers to implementing new therapies for diabetic kidney disease: lessons learned Adv Chronic Kidney Dis 28 318-327
[5]  
Kestenbaum B(2018)The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis Int Urol Nephrol 50 301-312
[6]  
Neumiller JJ(2022)Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Care 45 3075-3090
[7]  
Alicic RZ(2021)Management of type 2 diabetes in chronic kidney disease BMJ Open Diabetes Res Care 9 923-1049
[8]  
Tuttle KR(2022)American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update Endocr Pract 28 S1-S127
[9]  
Shi Y(2022)KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Kidney Int 102 S49-S67
[10]  
Xiong J(2023)4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes–2023 Diabetes Care 46 1-18